Global survey of the frequency of atrial fibrillation-associated stroke: embolic stroke of undetermined source global registry by Perera, Kanjana S. et al.
  
 
 
 
 
Perera, K. S. et al. (2016) Global survey of the frequency of atrial fibrillation-
associated stroke: embolic stroke of undetermined source global registry. Stroke, 
47(9), pp. 2197-2202. 
   
There may be differences between this version and the published version. You are 
advised to consult the publisher’s version if you wish to cite from it. 
 
 
 
 
 
http://eprints.gla.ac.uk/123224/ 
     
 
 
 
 
 
 
Deposited on: 08 September 2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
 1 
Global survey of the frequency of atrial fibrillation-associated stroke: 
ESUS Global Registry  
 
             Cover Title: Global frequency of AF-associated stroke 
 
Kanjana S. Perera, M.B., B.S. 
Department of Medicine (Neurology) 
McMaster University 
Hamilton Health Sciences 
Hamilton, Ontario, Canada 
 
Thomas Vanassche, M.D. 
Department of Cardiovascular Sciences 
University of Leuven 
Leuven, Belgium 
 
Jackie Bosch, Ph.D. 
Population Health Research Institute McMaster University 
Hamilton Health Sciences 
Hamilton, Ontario, Canada 
 
Balakumar Swaminathan, M.Sc 
Population Health Research Institute McMaster University 
Hamilton Health Sciences 
Hamilton, Ontario, Canada 
 
Hardi Mundl, M.D. 
Bayer -Pharma AG 
Wuppertal, Germany 
 
Mohana Giruparajah, B.Sc 
Population Health Research Institute McMaster University 
Hamilton Health Sciences 
Hamilton, Ontario, Canada 
 
Miguel A. Barboza, M.D. 
Instituto Nacional de Neurologia y Neurocirugia 
Mexico D.F., Mexico 
 
Martin J. O’Donnell, M.B.B.S. 
University of Galway 
Galway, Ireland 
 
Maia Gomez-Schneider, M.D. 
Institute for Neurological Research 
Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia (FLENI) 
Buenos Aires, Argentina 
 
Graeme J. Hankey, M.D. 
School of Medicine and Pharmacology 
University of Western Australia 
Sir Charles Gairdner Hospital 
Perth, Australia 
 
 2 
Byung-Woo Yoon, M.D. 
Department of Neurology 
Seoul National University Hospital 
Seoul, Korea 
 
Roxas A Jr, M.D. 
Medical City Hospital 
Manila, Philippines 
 
Philippa Lavallee, M.D. 
Department of Neurology 
Bichat Hospital 
Paris, France 
 
Joao Sargento-Freitas, M.D. 
Centro Hospitalar e Universitário de Coimbra 
Coimbra, Portugal 
 
Nikolay Shamalov, M.D. 
Pirogov Russian National Research Medical University 
Moscow, Russia 
 
Raf Brouns, M.D. 
Universitair Ziekenhuis Brussel 
Brussels, Belgium 
 
Rubens J. Gagliardi, M.D. 
Santa Casa de São Paulo, Medical School 
Sao Paulo, Brazil 
 
Scott E. Kasner, M.D. 
Department of Neurology 
Hospital of the University of Pennsylvania 
Philadelphia, United States 
 
Alessio Pieroni, M.D. 
Emergency Department Stroke Unit 
Hospital Policlinico Umberto I 
Dept. of Neurology and Psychiatry, ‘Sapienza’ University  
Rome, Italy 
 
Philipp Vermehren, M.D. 
Department of Neurology 
University Hospital Heidelberg 
Heidelberg, Germany 
 
Kazuo Kitagawa, M.D. 
Department of Neurology 
Tokyo Women’s Medical University 
Tokyo, Japan 
 
Yongjun Wang, M.D. 
Department of Neurology 
Beijing Tiantan Hospital 
Capital Medical University 
Beijing, China 
 3 
 
Keith Muir, MD., FRCP. 
Institute of Neuroscience & Psychology 
University of Glasgow, 
Queen Elizabeth University Hospital 
Glasgow, United Kingdom 
 
Jonathan M. Coutinho, M.D. PhD Academic Medical Center 
Amsterdam, Netherlands 
 
Stuart J. Connolly, M.D.  
Department of Medicine (Cardiology) 
Population Health Research Institute 
McMaster University 
Hamilton Health Sciences 
Hamilton, Ontario, Canada 
 
Robert G. Hart, M.D.  
Department of Medicine (Neurology) 
Population Health Research Institute 
McMaster University 
Hamilton Health Sciences 
Hamilton, Ontario, Canada 
 
On behalf of the ESUS Global Registry Investigators 
 
Address correspondence to: 
Kanjana S. Perera, M.B.,B.S 
Population Health Research Institute 
DBCVSRI C4-106 
237 Barton Street East 
Hamilton, Ontario L8L 2X2 Canada  
Email: kanjana.perera@phri.ca 
Telephone: 905-521-2100 ext 40367 
Fax: 905-577-1427 
 
Key words: atrial fibrillation, stroke, cerebral embolism 
 
Word count: abstract-250      text-3711 
Tables: 4 
Figures: 2 
 
 
 
 
 
 
 
 
 4 
Abstract 
Background: 
Atrial fibrillation (AF) is increasingly recognized as the single most important cause of 
disabling ischemic stroke in the elderly. We undertook an international survey to 
characterize the frequency of AF-associated stroke, methods of AF detection, and patient 
features. 
 
Methods: 
Consecutive patients hospitalized for ischemic stroke in 2013-2014 were surveyed from 
19 stroke research centers in 19 different countries. Data were analyzed by global regions 
and World Bank income levels. 
 
Results:  
Of 2144 patients with ischemic stroke, 590 (28%, 95%CI: 25.6-29.5%) had AF-
associated stroke, with highest frequencies in North America (35%) and Europe (33%) 
and lowest in Latin America (17%). Most had a history of AF prior to stroke (15%) or 
newly detected AF on ECG (10%); only 2% of ischemic stroke patients had unsuspected 
AF detected by post-stroke cardiac rhythm monitoring. The mean age and 30-day 
mortality rate of patients with AF-associated stroke (75 years, SD=11.5 years; 10%, 
95%CI: 7.6-12.6%, respectively) were substantially higher than for patients without AF 
(64 years, SD=15.58years; 4%, 95% CI:3.3-5.4%, p<0.001 for both comparisons). There 
was a strong positive correlation between mean age and the frequency of AF (r=0.76; 
p=0.0002). 
 
Conclusions: 
This cross-sectional global sample of patients with recent ischemic stroke shows a 
substantial frequency of AF-associated stroke throughout the world in proportion to the 
mean age of the stroke population. Most AF is identified by history or ECGs; the yield of 
conventional short-duration cardiac rhythm monitoring is relatively low. Patients with 
AF-associated stroke were typically elderly (>75 years old) and more often women.  
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Introduction: 
Atrial fibrillation (AF) is increasingly recognized as an important cause of ischemic 
stroke whose importance is magnified because of the remarkable efficacy of oral 
anticoagulants for stroke prevention.(1,2)  Hospital-based  registry data from the 1980s 
and 1990s,  estimated that 16% of ischemic strokes were associated with AF.(3) However, 
studies published in the past decade consistently report higher frequencies,(4- 7) possibly 
due to increased surveillance and inclusion of older stroke cohorts. 
 
The frequency and features of AF-associated stroke across global regions have not been 
previously studied, as data have primarily been collected from Europe and North 
America. Here, we report the prevalence of AF-associated stroke from 19 stroke centers 
in 19 countries and compare features with ischemic stroke not associated with recognized 
AF. 
 
Methods: 
The design and initial findings from the ESUS (Embolic Stroke of Undetermined Source) 
Global Registry have been previously published (8). Consecutive patients with recent 
ischemic stroke were obtained from 19 stroke centers in 19 different countries, targeting 
review of 100 patients with acute ischemic stroke at each site. Sites were instructed to 
retrospectively identify consecutive inpatients evaluated for recent stroke in 2013- 2014 
from hospital discharge diagnosis codes or from databases associated with acute stroke 
units. The study complied with local institutional research board regulations; informed 
consent was not required at any site for this anonymized data collection. Data were 
entered into a central database at the Population Health Research Institute via on-line data 
entry or via an automated fax-based data entry system. Missing data were queried, and 
final data were exported to STATA 13.0 for statistical analysis.  
 
AF-associated stroke was defined as an ischemic stroke associated with any history of 
AF, AF on any ECG done for the index stroke, or AF detected on cardiac rhythm 
monitoring (including inpatient telemetry or ambulatory monitoring with automated 
rhythm detection) done after stroke. Given the nature of the global registry data were not 
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collected about the duration of paroxysmal AF or about antithrombotic therapy before or 
after stroke. 
 
Data were analyzed according to four global regions: Europe (9 sites), North America (2 
sites), Latin America (3 sites), East Asia/Pacific (5 sites). Sites were also grouped into 
four World Bank income groups (low, lower-middle, upper-middle and high) (World 
Bank Group http://data.worldbank.org/about/country-classifications).  
 
Categorical data were summarized as counts and percentages and comparisons were 
made using Chi-Square test. Continuous data were summarized using mean and standard 
deviation and comparisons were made using t-test or Wilcoxon rank test, as appropriate. 
Correlation coefficient was used to determine the association between mean age of stroke 
cohort and the frequency of AF among centers. All analyses were performed using SAS 
software, version 9.2 (SAS Institute Inc., Cary, NC).  A 2-sided p-value of <0.05 was 
considered statistically significant. 
 
Results: 
Frequency of AF-associated stroke by site, global region, and age  
Of 2144 patients with recent ischemic stroke (mean age 67 years, SD = 15.39 years) 
collected from 19 stroke research centers in 19 countries, the frequency of AF-associated 
stroke was 28% (95% CI: 25.6-29.5%), ranging from 11% in Manila, Philippines to 45% 
in Galway, Ireland (Table 1).  The prevalence of AF-associated stroke was highest at sites 
in Europe (33%) and North America (35%) and lowest at Latin American sites (17%), 
(Table 2). When comparing the 14 sites from high income countries (n=1516) and 5 sites 
from upper-middle income countries (n=628), the prevalence of AF-associated stroke was 
higher at sites in high-income countries (32.5%, 95% CI: 30.1% - 34.8%) compared to 
upper middle income countries (15.6%, 95% CI: 12.8% - 18.4%) (Figure 1) 
 
Patients with AF-associated stroke were, on average, substantially older (mean age 75 
years, SD = 11.45 years), than patients with ischemic stroke unassociated with AF (mean 
age 64 years, SD = 15.51 years) (p<0.001), and this decade difference was consistent 
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across global regions (Table 2). There was a strong and significant correlation between 
the mean age of the stroke cohort and the frequency of AF among sites (Figure 2). 
 
 
 
Identification of AF among ischemic stroke patients 
Of the 590 ischemic strokes associated with AF, 332 (56%, 95%CI: 52.1%-60.3%) had a 
history of AF prior to the index stroke, and an additional 207 (35%, 95%CI: 31.2-39.1%) 
without a history of AF had AF diagnosed by ECG done for evaluation of the index 
stroke, and 51(8%, 95% CI: 6.4% - 10.9%) had AF diagnosed by prolonged cardiac 
rhythm monitoring(Table 3). In our study cohort of 2144 ischemic stroke patients, 1108 
(69%) patients, (who did not have a diagnosis of AF prior to the index stroke or who were 
not diagnosed with AF on the basis of a 12 lead ECG), underwent > 24 hour cardiac 
rhythm monitoring and the yield of cardiac rhythm monitoring to detect AF was 4.6%.  
 
Clinical features of ischemic stroke patients with and without associated AF 
In patients with AF-associated stroke only 6% presented with a lacunar stroke (<1.5cm in 
largest diameter subcortical or pontine infarct) as their index stroke, this was significantly 
lower than the non-AF associated stroke patients where 20% presented with lacunar 
stroke as their index stroke. 9% of the AF patients had > 50% stenosis in the ipisilateral 
cervical carotid artery detected by ultra sound Doppler, magnetic resonance angiography 
or computed tomographic angiography. In the non-AF ischemic stroke patients 15% had 
> 50% ipsilateral carotid stenosis.  30 day mortality among AF patients was significantly 
higher (10%, 95% CI: 7.6-12.6) compared to non-AF ischemic stroke patients (4%, 95% 
CI: 3.3-5.4%) (p<0.0001).  
 
Relationship between the frequency of AF-associated stroke and the mean age of the 
ischemic stroke cohort 
Overall, AF was more common in those >75 years (44%) versus those < 75 years (18%) 
(p=0.0001), with almost half of the ischemic strokes in women >75 years associated with 
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AF (46%). There was a strong positive correlation between mean age of stroke patients 
and frequency of AF among sites. (r=0.76; p = 0.0002) 
 
Discussion: 
This global registry project demonstrates that AF-associated ischemic stroke is common: 
28% of ischemic strokes at the 19 international sites and one-third of strokes at sites in 
Europe and North America. Our findings show that patients with AF were almost a 
decade older than patients without AF across global regions. Differences in prevalence 
between sites and regions are largely due to the variation in mean ages of the stroke 
populations. The attributed risk of AF for ischemic stroke in a given population is 
expected to be influenced by the life expectancy of the population, (9), and this might 
partly explain regional variations in frequency of AF between high- income and upper 
middle- income countries in our study. 
 
AF was identified in 28% (95% CI: 25.6-29.5%) of consecutive ischemic stroke patients, 
a higher fraction than in hospitalized ischemic stroke patients in past decades (typically 
between 15-20%)(3) probably due to both increasing vigilance in detecting AF, the 
increasing prevalence of AF in the elderly(9), and inclusion of more elderly stroke 
cohorts.  Recent studies published since the Registry demonstrate that prolonged (>1 
month) cardiac rhythm monitoring identifies additional patients with cryptogenic stroke 
who have episodes of paroxysmal atrial fibrillation,(10,11) which are often very brief and 
of uncertain etiologic relevance.(12)  The increase in the frequency of AF-associated 
stroke relative to other ischemic strokes has occurred despite more widespread use of oral 
anticoagulation in AF patients.(9) More than half of AF-related strokes occurred in 
patients with a known history of AF. Although no data on antithrombotic or anticoagulant 
therapy was available, this finding stresses the importance of optimizing stroke 
prevention in patients with known AF. 
 
In our stroke cohort 6% of the patients with AF had lacunar stroke as their index stroke 
compared to 20% of patients without AF, and the differences in frequency were 
consistent across global regions and consistent with previous studies, suggesting that AF-
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related strokes are more frequently larger. It must be acknowledged that accurate 
subtyping of stroke may not be possible in all cases even with advanced neuroimaging 
and vascular imaging techniques and that some “lacunar” strokes could have cardio 
embolic or atheroembolic sources. However previously published data on anticoagulation 
treatment in patients with AF who present with lacunar stroke shows no benefit of 
anticoagulation compared to antiplatelet treatment in reducing the risk of recurrent stroke. 
(13,14) With this knowledge, it would have been interesting to explore whether stroke 
subtype influenced physician decision on choosing an anti-thrombotic for secondary 
stroke prevention. Unfortunately we did not collect data on the discharge antithrombotic 
in our study cohort.  
 
In our study cohort, the 30 day mortality was significantly higher for patients with AF 
when compared to patients without AF across global regions. Our findings are consistent 
and in accordance with the larger randomized trials.   
 
Our findings show a significant correlation between the mean age of stroke patients and 
frequency of AF which is statistically significant and in keeping with several recent 
observational data. (9,16,17) 
 
Limitations of this study include participation by a limited number of selected, high-
volume stroke centers and therefore the results may not be generalizable to all patients 
with ischemic stroke. A single site in each country may not accurately reflect the 
frequency of AF for the country. This hospital/stroke unit-based registry did not capture 
stroke patients who were not hospitalized for stroke. Due to the primary reason of the 
registry, several interesting stroke-related data such as therapy, outcome, cardiovascular 
risk factors, etc. were only collected in the subgroup of ESUS patients and thus not 
available for patients with AF-related stroke.  
However, the study sites represented many global regions allowing unique comparison of 
AF-associated stroke around the world and the frequency of AF in our study (28%) is 
broadly in line with figures reported in recent studies, supporting the external validity of 
our findings.  
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In summary, this study provides a unique perspective on the global burden of AF-
associated stroke.  AF-associated stroke comprises an important (28%, 95% CI: 25.6-
29.5%) subset of ischemic stroke patients around the world, and is the most frequent 
cause of ischemic stroke in elderly women. These strokes are potentially preventable. 
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Table 1. Frequency of atrial fibrillation among ischemic stroke patients  
 
 All Ischemic Stokes  
Site* N 
Mean age (SD) 
in years 
Atrial Fibrillation 
associated stroke 
N(%) 
Manila, Philippines 175 62 (0.50) 20 (11%) 
Mexico City, Mexico 225 56 (0.50) 30 (13%) 
Beijing, China 69 59 (0.46) 11 (16%) 
Amsterdam, Netherlands 99 68 (0.50) 17 (17%) 
Moscow, Russia 106 66 (0.50) 18 (17%) 
Rome, Italy 91 67 (0.50) 19 (21%) 
Tokyo, Japan 75 68 (0.49) 16 (21%) 
Buenos Aires, Argentina 73 68 (0.50) 16 (22%) 
Sao Paulo, Brazil 86 60 (0.49) 21 (24%) 
Perth, Australia 114 67 (0.48) 32 (28%) 
Philadelphia, United States 120 67 (0.50) 38 (32%) 
Paris, France 69 69 (0.49) 23 (33%) 
Heidelberg, Germany 91 73 (0.50) 30 (33%) 
Seoul, South Korea 124 69 (0.49) 43 (35%) 
Hamilton, Canada 172 73 (0.50) 65 (38%) 
Brussels, Belgium 119 74 (0.50) 46 (39%) 
Glasgow, United Kingdom 73 67 (0.50) 29 (40%) 
Coimbra, Portugal 123 74 (0.49) 53 (43%) 
Galway, Ireland 140 71 (0.50) 63 (45%) 
Total 2144 67 (0.50) 590 (28%) 
 *See appendix for specific hospitals, institutions and investigators 
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Table 2. Frequency of atrial fibrillation among ischemic stroke patients by global region 
 Overall Europe (9 sites) North America (2 sites) 
 N (%) 
Men 
n (%) 
Mean 
age 
(yrs.) N (%) 
Men 
n (%) 
Mean 
age 
(yrs.) N (%) 
Men 
n (%) 
Mean 
age 
(yrs.) 
Ischemic stroke – all 2144 (100%) 1175 (55%) 67 911 (100%) 508 (56%) 70 292 (100%) 149 (51%) 70 
Ischemic stroke with AF* 590 (28%) 295 (50%) 75 298 (33%) 151 (51%) 77 103 (35%) 49 (48%) 77 
Ischemic stroke  - no AF 1554 (72%) 880 (57%) 64 613 (67%) 357 (58%) 67 189 (65%) 100 (53%) 67 
 
 Latin America (3 sites) East Asia and Pacific (5 sites) 
 N (%) 
Men 
n (%) 
Mean 
age 
(yrs.) N (%) 
Men 
n (%) 
Mean 
age 
(yrs.) 
Ischemic stroke 384 (100%) 180 (47%) 59 557 (100%) 338 (61%) 65 
Ischemic stroke with AF* 67 (17%) 30 (45%) 67 122 (22%) 65 (53%) 74 
Ischemic stroke - no AF 317 (83%) 150 (47%) 58 435 (78%) 273 (63%) 62 
 
AF = atrial fibrillation 
*History of AF prior to index stroke, AF on any ECG, or AF documented on post-stroke cardiac rhythm monitoring. 
 
 
. 
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Table 3. Identification of atrial fibrillation among ischemic stroke patients by global regions 
 
All Regions 
(19 sites) Europe   
(9 sites) 
North 
America 
(2 sites) 
Latin 
America 
(3 sites) 
East Asia and 
Pacific 
(5 sites) 
 N  %* N %* N %* N %* N %* 
All ischemic strokes 2144 100% 911 100% 292 100% 384 100% 557 100% 
Total AF+ 590 28% 298 33% 103 35% 67 17% 122 22% 
History of AF prior to index stroke 332 15% 163 18% 70 24% 27 7% 72 13% 
AF on any ECG but no history of AF prior to  
index stroke 
207 10% 105 12% 28 10% 33 9% 41 7% 
AF on cardiac rhythm monitoring, but no AF on  
any ECG and no history of AF (i.e. detected only  
by monitoring) 
51^ 2% 30 3% 5 2% 7 2% 9 2% 
AF = atrial fibrillation 
* Percent of all ischemic strokes. 
+ includes a history of AF prior to index stroke, AF on any ECG, or AF on post-stroke cardiac rhythm monitoring. 
^ Of 1605 ischemic stroke patients without AF by history or ECG 
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Table 4. Clinical features of ischemic stroke patients according to atrial fibrillation by global regions 
 
 Overall 
Europe and 
Central Asia 
(9 sites) 
North America 
(2 sites) 
Latin America 
(3 sites) 
East Asia and 
Pacific 
(5 sites) 
 
AF 
(n=590) 
No AF 
(n=1554) 
pvalue 
Chi-Sq AF No AF AF No AF AF No AF AF No AF 
Participants with age >=75 years 
- n(%) 
337 
(57%) 425 (27%) <.0001 
186 
(62%) 
211 
(34%) 65 (63%) 58 (31%) 
26 
(39%) 
64 
(20%) 
60 
(49%) 
92 
(21%) 
Women >=75 years - n(%) 191 
(32%) 
222 (14%) <.0001 109 
(37%) 
109 
(18%) 
40 (39%) 34 (18%) 15 
(22%) 
35  
(11%) 
27 
(22%) 
44 
(10%) 
 
Cardiac rhythm monitoring >=24 
hours after stroke - n(%) 
370 
(63%) 
1049 (68%) 0.0362 195 
(65%) 
415 
(68%) 
53 (51%) 166 (88%) 36 
(54%) 
147 
(46%) 
86 
(70%) 
321 
(74%) 
 
Lacunar infarct visualized on 
CT/MRI* - n(%) 
33  
(6%) 
306 (20%) <.0001 11 (4%) 109 
(18%) 
7 (7%) 26 (14%) 4 (6%) 38 
(12%) 
11 
(9%) 
133 
(31%) 
 
Ipsilateral cervical carotid 
stenosis > 50% or occlusion - 
n(%) 
55  
(9%) 
238 (15%) 0.0003 29 
(10%) 
95 (15%) 17 (17%) 35 (19%) 5 (7%) 49 
(15%) 
4 (3%) 59 
(14%) 
 
Death within 30 days - n(%) 58 
(10%) 
66 (4%) <.0001 36 
(12%) 
35 (6%) 18 (17%) 20 (11%) 1 (1%) 3 (1%) 3 (2%) 8 (2%) 
 
AF = atrial fibrillation 
* Small (<1.5cm in largest diameter) subcortical or pontine infarct. 
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 Figure 1:  Frequency of AF and mean age according to country income strata 
 
 
 
 
 
Non AF 68% 
Mean age 67y 
AF 32% 
 Mean age  77y 
High-income countries - 14 sites 
Non AF 84%  
Mean age 58y 
AF 16%    
Mean age 
69y 
Upper-middle income countries - 5 sites 
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Figure 2. Relationship between the frequency of AF-associate stroke and the mean age of 
the ischemic stroke cohort. 
 
 
